Johnson & Johnson, GE, Apple, Medtronic, and Alphabet, with each earning a five-star rating on GlobalData’s Medical Devices Thematic Scorecard. For instance, between October 2020 and September 2021, Johnson & Johnson advertised 969 new artificial intelligence jobs and cited artificial intelligence 30 times in corporate filings.
GE exhibited a strong commitment to AI investment, with the firm seeking 446 new artificial intelligence jobs from October 2020 and referencing the technology 50 times in filings. Since October 2020, GlobalData analysts have graded the top firms in the medical devices market based on their artificial intelligence performance, as well as the number of new artificial intelligence positions, agreements, patents, and references in corporate reports.
Increased figures often suggest that a business has invested more time and money in enhancing its artificial intelligence performance, or that artificial intelligence is at the forefront of executives’ minds. However, this does not always imply that it is outperforming the competition.
A high frequency of references of artificial intelligence in quarterly corporate filings might suggest that the firm is reaping the benefits of prior efforts or that it has to invest more to stay competitive. Similarly, a large number of transactions may suggest that a firm is either leading the market or is utilizing mergers and acquisitions to close gaps in its offering. However, these patterns provide insight into how senior executives in the medical devices business, and in particular, at certain organizations, view artificial intelligence and how much their future depends on it.
